Actuate Therapeutics

(NASDAQ) ACTU

Current Price$3.35

Market Cap$70.89M

Since IPO (2024)-65%

5 YearN/A

1 Year-64%

1 Month+58%

Actuate Therapeutics Financials at a Glance

Market Cap

$70.89M

Revenue (TTM)

$0.00

Net Income (TTM)

$22.23M

EPS (TTM)

$-1.08

P/E Ratio

-2.78

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$3.35

Volume

156,869.902

Open

$2.98

Price

$3.35

Volume

156,869.902

Open

$2.98

Previous Close

$3.34

Daily Range

$2.84 - $3.42

52-Week Range

$1.58 - $11.99

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$3.35

Volume

156,869.902

Open

$2.98

Previous Close

$3.34

Daily Range

$2.84 - $3.42

52-Week Range

$1.58 - $11.99

ACTU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Actuate Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Daniel M. Schmitt, MBA

Website

www.actuatetherapeutics.com

Headquarters

Fort Worth, TX 76107, US

ACTU Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-554%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-35.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$70.89M

Shares Outstanding

23.71M

Volume

156.87K

Avg. Volume

120.53K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$22.50M

EBITDA

$22.50M

Operating Cash Flow

$19.21M

Capital Expenditure

$0.00

Free Cash Flow

$19.21M

Cash & ST Invst.

$13.16M

Total Debt

$404.99K

Actuate Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$70.89M

N/A

Market Cap/Employee

$7.09M

N/A

Employees

N/A

Net Income

$4.55M

+29.4%

EBITDA

$4.69M

+25.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$12.75M

+47.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$404.99K

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.58%

N/A

Return on Invested Capital

-2.70%

N/A

Free Cash Flow

$3.74M

+21.7%

Operating Cash Flow

$3.74M

+21.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.72-3.50%

VORVor Biopharma Inc.

VORVor Biopharma Inc.$16.08+1.13%

VTGNVistaGen Therapeutics, Inc.

VTGNVistaGen Therapeutics, Inc.$0.59-3.88%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.79-2.98%

APLTApplied Therapeutics, Inc.

APLTApplied Therapeutics, Inc.$0.10+0.00%

SPROSpero Therapeutics, Inc.

SPROSpero Therapeutics, Inc.$2.51-0.79%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.10-4.33%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

INTCIntel

INTCIntel$109.62-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

IRENIren

IRENIren$56.85-0.07%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

Questions About ACTU

What is the current price of Actuate Therapeutics?

Actuate Therapeutics is trading at $3.34 per share.

What is the 52-week range for Actuate Therapeutics?

Over the past 52 weeks, Actuate Therapeutics has traded between $1.58 and $11.99.

How much debt does Actuate Therapeutics have?

As of the most recent reporting period, Actuate Therapeutics reported total debt of $404,991.

How much cash does Actuate Therapeutics have on hand?

Actuate Therapeutics reported $13.16M in cash and cash equivalents in its most recent financial results.

What is Actuate Therapeutics’s dividend yield?

Actuate Therapeutics does not currently have a dividend yield.

Actuate Therapeutics

Actuate Therapeutics Financials at a Glance

ACTU News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Actuate Therapeutics

ACTU Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Actuate Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACTU

What is the current price of Actuate Therapeutics?

What is the 52-week range for Actuate Therapeutics?

How much debt does Actuate Therapeutics have?

How much cash does Actuate Therapeutics have on hand?

What is Actuate Therapeutics’s dividend yield?

Premium Investing Services